October 17, 2011 10:35 AM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Shares of Anadys Pharmaceuticals (NASDAQ: ANDS) are higher on the session by 250.10%, currently trading at $3.641. The stock has been moving largely higher over the past three months and is currently trading above the 50-day moving average.Options traders are focusing on calls today. A short while ago the December 2011 $2.00 call traded 740 times on open interest of 670 contracts. Anadys Pharmaceuticals just entered into and agreement to be acquired by Roche for $3.70 per share.Calls are outpacing puts today by 50 to 1. Anadys Pharmaceuticals, Inc. is a biopharmaceutical company engaged in developing medicines for the treatment of hepatitis C. The company is developing ANA598, a small-molecule, non-nucleoside inhibitor of the NS5B polymerase for the treatment of hepatitis C.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.